Rockwell Medical Technologies (NASDAQ: RMTI) reported Q2 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $13.86 million.

For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.